Embed Size (px)
Citation preview
Volume 60 ■ Number 1 ■ March 2008 ■ ISSN 0031-6997
A Publication of the
American Society for
Pharmacology and
Experimental Therapeutics
PHARMACOLOGicalPHARMACOLOGical
REVIEWS
zpg0010800SPC1.qxd 3/11/08 3:31 PM Page 1
Ross D. Feldman, EditorEric P. Brass, Deputy Editor
ASSOCIATE EDITORSStephen P. Alexander
Nottingham, UnitedKingdom
Annette DolphinLondon, United Kingdom
David FlockhartWashington, DC
Bertil FredholmStockholm, Sweden
Glenda E. GilliesLondon, United Kingdom
Stephen D. HallIndianapolis, Indiana
Perry V. HalushkaCharleston, South
CarolinaPaul A. Insel
La Jolla, CaliforniaRalph E. Kauffman
Kansas City, MissouriMarkku Koulu
Turku, Finland
Yoshihisa KurachiKobe, Japan
Dan L. LongoBaltimore, Maryland
Joaquin MadrenasLondon, Canada
Mark P. MattsonBaltimore, Maryland
Theresa ShapiroBaltimore, Maryland
Burt SharpMemphis, Tennessee
Daniel L. SimmonsProvo, Utah
Ulf SimonsenTrige, Denmark
Adam SmithStockholm, Sweden
C. Michael SteinNashville, Tennessee
Per Margne UelandBergen, Norway
Anton WellsteinWashington, DC
ASPET BOARD OF PUBLICATIONS TRUSTEESJames E. Barrett, Chair; Jeffrey Conn, Ross D. Feldman, Lorraine J. Gudas, Eric F. Johnson, John S. Lazo,
Edward T. Morgan, Richard R. Neubig, Rick G. Schnellmann, Darryle D. Schoepp, and Mary VoreASPET EXECUTIVE OFFICER: Christine K. Carrico
JOURNALS DIRECTOR: Richard DodenhoffMANAGING EDITOR: Jill Filler
Editorial supervision of Pharmacological Reviews is shared jointly with theBritish Pharmacological Society and the Scandinavian Pharmacological Societies.
Pharmacological Reviews (ISSN 0031-6997) is published quarterlyin March, June, September, and December by the American Society forPharmacology and Experimental Therapeutics, 9650 Rockville Pike,Bethesda, MD 20814-3995; email: [email protected]; web site: www.aspet.org; journal web site: pharmrev.aspetjournals.org. Periodicalspostage paid at Bethesda, MD, and at additional mailing offices.POSTMASTER: Send address changes to Pharmacological Reviews,9650 Rockville Pike, Bethesda, MD 20814-3995. Subscription rates:U.S.: $256.00 for institutions and $145.00 for individuals. Outside theU.S.: $301 for institutions and $190 for individuals. Single copy:$69.00. GST Tax Number for Canadian subscribers: BN:13489 2330FT. Institutional and individual subscriptions include access to theonline version of Pharmacological Reviews (pharmrev.aspetjournals.org).Indexed or abstracted by: Biological Abstracts, BIOSIS PreviewsDatabase, Biosciences Information Service, Current Contents®/LifeSciences, EMBASE/Excerpta Medica, Index Medicus, Index to Sci-entific Reviews®, Medical Documentation Service®, Reference Up-date®, Research Alert®, Science Citation Index®, and SciSearch®.ASPET office: 9650 Rockville Pike, Bethesda, MD 20814-3995;telephone: 301-634-7060; fax: 301-634-7061; email: [email protected];web site: www.aspet.org.Editorial matters should be addressed to Dr. Ross D. Feldman,Editor, Pharmacological Reviews, at the above address.Official version: The online version of Pharmacological Reviewscontains all of the information and material contained in the printversion plus additional material that may not appear in print suchas videos and large data sets. The online version may be morecurrent than the print version. Where noted, the online version hasbeen corrected in departure from the print version. The onlineversion of Pharmacological Reviews officially published by theAmerican Society for Pharmacology and Experimental Therapeuticsis the definitive version and, to the extent any difference exists, willprevail over the print version.Instructions to Authors: See pharmrev.aspetjournals.org for theInstructions to Authors and the ASPET Authorship Responsibility,Financial Disclosure, and Copyright Transfer form.Subscriptions: Contact the ASPET Subscriptions Dept., 9650Rockville Pike, Bethesda, MD 20814-3995; telephone: 301-634-7782; fax: 301-634-7061; email: [email protected]. Formulti-site and consortia sales in Europe, contact: David Charles,eLicensing, 92 avenue du General de Gaulle, 78600, Maisons-
Laffitte, France; telephone: �33-1-39-12-29-29; fax: �33-1-39-12-47-45; email: [email protected] of address: ASPET must be notified 60 days in advance.Copies undeliverable because of incorrect address will be destroyed.Duplicate copies may be obtained, if available, from ASPET at thesingle copy price. Send address changes to the ASPET office.Issue replacement policy: Domestic subscribers—Claims for non-delivery of issues must be made within three (3) months of issuemail date. Foreign subscribers—Claims for nondelivery of issuesmust be made within six (6) months of issue mail date. MissingIssues (domestic and foreign)—ASPET will not honor refunds orreplacement requests made outside of the claim time period. Up toone (1) issue will be replaced free of charge per subscription year.Reprints in large quantities for commercial or academic usemay be purchased from ASPET. For information and prices, call301-634-7063.Copyright information: Pharmacological Reviews is copyrightedby the American Society for Pharmacology and Experimental Ther-apeutics. For permission to photocopy or use material electronicallyfrom Pharmacological Reviews, see www.copyright.com or contactthe Copyright Clearance Center (CCC), Inc., 222 Rosewood Dr.,Danvers, MA 01923; telephone: 978-750-8400. Photocopying of ar-ticles beyond that permitted by Sections 107 and 108 of the U.S.Copyright Law is allowed, provided that the $20.00-per-copy fee ispaid through the CCC. Classroom photocopying is permitted at nofee, provided that students are not charged more than the cost ofduplication. This consent does not extend to other kinds of copying.Reproduction of any portion of an article for subsequent republica-tion requires permission of ASPET. Write to the ASPET office at theabove address. Requests should include a statement of intended useas well as explicit specifications of the materials to be reproduced.Disclaimer: The statements and opinions contained in the articlesof Pharmacological Reviews are solely those of the individual au-thors and contributors and not of the American Society for Pharma-cology and Experimental Therapeutics. The appearance of adver-tisements in the journal is not a warranty, endorsement, orapproval of the products or their safety. The American Society forPharmacology and Experimental Therapeutics disclaims responsi-bility for any injury to persons or property resulting from any ideasor products referred to in any article or advertisement.Copyright © 2008 by the American Society for Pharmacology andExperimental Therapeutics. All rights reserved. Printed in theU.S.A.
PHARMACOLOGICAL REVIEWSA Publication of the American Society for Pharmacology and Experimental Therapeutics
Louis S. Goodman, Founding Editor, 1949
WE AREThe Federation of American Societies forExperimental Biology is a coalition of lifescience societies dedicated to enhancingthe quality of life through research. If youare a member of the American Societyfor Pharmacology and Experimental
Therapeutics you—like more than 65,000other scientists—are a member of FASEB.FASEB strives to provide support inpublic affairs, distinguished publications,invaluable meetings and conferences, anda variety of member services.
FASEB—we are life scientists and we work for you. www.faseb.org
WE AREPHARMACOLOGISTS
IUPHAR Nomenclature ReportInternational Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors:
Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal andDisease States
R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya
1
Review ArticlesVertebrate Membrane Proteins: Structure, Function, and Insights from Biophysical
ApproachesDaniel J. Muller, Nan Wu, and Krzysztof Palczewski
43
Pharmacological and Clinical Aspects of Heme OxygenaseNader G. Abraham and Attallah Kappas
79
Sortase as a Target of Anti-Infective TherapyAnthony W. Maresso and Olaf Schneewind
128
ErratumCorrection to “5-HT Receptor Regulation of Neurotransmitter Release” 142
About the cover: In the article by Maresso and Schneewind (page 128), high-throughput screeningidentifies mechanism-based inhibitors of sortase. The crystal structure of sortase with the AAEKinhibitors identified keystone interactions and ionic pockets that can be exploited for inhibitorimprovement.
PHARMACOLOGICALREVIEWS
A Publication of the American Society for Pharmacology and Experimental Therapeutics
March 2008 Volume 60, Number 1
